Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJK4J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,190
Award facts
- Contract value 100% obligated
- $15,189.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,189.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) pre-filled pens on January 28, 2026, with an ultimate completion date of January 29, 2026. This non-competitive delivery order, performed at the contractor's Conshohocken, Pennsylvania location, represents a task order under a larger Indefinite Delivery Contract vehicle. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company holds a significant $999.999 billion IDC with DLA Troop Support Medical (designation SPE2DX) running through December 2026, which serves as the comprehensive global pharmaceutical support vehicle enabling supply of a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
This award supports federal healthcare operations through delivery of Ozempic, a diabetes medication commonly used across the Defense Health Agency and military treatment facilities. The no-set-aside designation indicates this delivery order was competitively awarded, consistent with AmerisourceBergen Drug Corp's established pattern of federal procurements structured as firm fixed-price orders. The rapid completion timeline reflects the urgent nature of pharmaceutical supply requirements within the military healthcare system, demonstrating the efficiency of the IDC delivery order mechanism for procuring critical medical commodities.
Quick answers
Who was awarded contract SPE2DR26FJK4J?
SPE2DR26FJK4J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FJK4J worth?
The government has obligated $15,190 on SPE2DR26FJK4J.
Is contract SPE2DR26FJK4J an order under another contract?
Yes. SPE2DR26FJK4J is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJK4J competed?
The extent of competition for SPE2DR26FJK4J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award